Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Retinal Angiomatous Proliferation”

8 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 8 of 8 results

Post-approval studies (Phase 4)Study completedNCT01006538
What this trial is testing

Macular EpiRetinal Brachytherapy Versus Lucentis® Only Treatment (MERLOT)

Who this might be right for
Macular Degeneration
King's College Hospital NHS Trust 363
Post-approval studies (Phase 4)UnknownNCT04655482
What this trial is testing

Treat-and-extend Using Aflibercept for Type 3 Neovascularization

Who this might be right for
Retinal Angiomatous Proliferation
Kim's Eye Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT07167329
What this trial is testing

Real-World Effectiveness and Pharmacogenetics of Belzutifan in VHL Syndrome: The BELIEVE-VHL Trial

Who this might be right for
Von Hippel LindauVon Hippel Lindau DiseaseVon Hippel Lindau-Deficient Clear Cell Renal Cell Carcinoma+5 more
José Claudio Casali da Rocha 100
Testing effectiveness (Phase 2)Study completedNCT00395707
What this trial is testing

Study To Determine Safety/Efficacy of Lucentis For Treatment Of Retinal Angiomatous Proliferation Secondary To Age Related Macular Degeneration

Who this might be right for
Macular Degeneration
The National Retina Institute 20
Post-approval studies (Phase 4)Not Yet RecruitingNCT07187804
What this trial is testing

Long Term Efficacy of Faricimab Using a Treat and Extend Regimen for Type 3 Macular Neovascularization

Who this might be right for
Age-related Macular Degeneration (ARMD)Choroidal NeovascularizationAnti-vascular Endothelial Growth Factor
Kim's Eye Hospital 30
Testing effectiveness (Phase 2)Study completedNCT00470977
What this trial is testing

Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy

Who this might be right for
Coats' DiseaseIdiopathic Retinal TelangiectasiaRetinal Angiomatous Proliferation+7 more
Manhattan Eye, Ear & Throat Hospital 18
Not applicableStudy completedNCT04689789
What this trial is testing

OCTA and Retinal Angiomatous Proliferation

Who this might be right for
Age Related Macular Degeneration
Federico II University 118
Post-approval studies (Phase 4)WithdrawnNCT04698850
What this trial is testing

Brolucizumab vs. Aflibercept for Retinal Angiomatous Proliferation

Who this might be right for
Wet Macular Degeneration
Faculty Hospital Kralovske Vinohrady